Searched for
RBD PROTEIN
Covaxin well tolerated in those not yet vaccinated in US: Study"Phase II/III observer-blind, immuno-bridging and broadening study was done to generate a broader immune response against the whole virus c...- Biological E seeks nod for bivalent vax trialsBiological E has developed the protein subunit Covid vaccine Corbevax. The antigen used in the vaccine was developed by Texas Children’s Ho...
- New easy-to-use test can now tell how much immunity people have against CovidThis technology is also the basis of most at-home rapid tests for Covid-19.
- New test can tell how much immunity you have against COVID-19US researchers have developed an easy-to-use test that can predict the degree of immune protection people have against COVID-19, either fro...
- IISc scientists develop miniproteins that may prevent COVID infectionResearchers at the Indian Institute of Science (IISc) Bangalore have designed a new class of artificial peptides or miniproteins that they ...
- IISc researchers provide alternative mechanism to render viruses like SARS-CoV-2 inactiveA protein-protein interaction is often like that of a lock and a key, the Bengaluru-based IISc noted in a statement. This interaction can b...
- Corbevax vaccine to cost Rs 990 in market, Rs 145 for governmentBiological E said that it is providing the most affordable Covid vaccine on a global scale due to process of innovation, large-scale manufa...
- Drug Controller General of India okays Corbevax for use in 12-18 age group"BE received the approval for restricted use in an emergency situation in adolescents aged 12 to less than 18 years based on interim result...
- Subject Expert Committee recommends EUA for BE's Covid jab Corbevax for 12-18 years age groupCorbevax, is a RBD protein sub-unit vaccine that has been developed with support from the Department of Biotechnology and the Biotechnology...
- Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age groupThe Drugs Controller General Of India (DCGI) has already approved Corbevax, which is India's first indigenously developed RBD protein sub-u...
- View: India needs to act fast to avoid flying blind into Omicron and beyondBooster doses will become available in India from January 10. The prioritisation and sequence of administration would be based on completin...
- BE hopes to roll out COVID-19 vaccine Corbevax by November-endSpeaking to reporters on the sidelines of signing a financing agreement with US International Development Finance Corporation (DFC), she sa...
- Covid antibody that protects against broad range of variants identifiedThe new antibody attaches to a part of the virus that differs little across the variants, meaning that it is unlikely for resistance to ari...
- IISc's 'warm' Covid vaccine effective against all major variants of concern: StudyAccording to S S Vasan, CSIRO's COVID-19 project leader and co-author of the study, the Mynvax-vaccinated mice sera show a strong response ...
- IISc start-up PathShodh gets regulatory approvals for Covid-19 testPathShodh has received the license from the Central Drugs Standard Control Organisation (CDSCO) to manufacture the test for sale, IISc said...
- 'Next-gen' COVID-19 vaccines may be needed to tackle emerging variants, say scientistsWork on vaccines will have to continue on parallel tracks - one to tackle the SARS-CoV-2 virus with first generation vaccines and the other...
- Indian researchers working towards developing effective vaccine strategies against SARS-CoV-2 and HIVIn two studies published in the past week, they reported the design of a 'heat-tolerant' Covid-19 vaccine candidate and a rapid method to i...
- Chinese COVID-19 vaccine candidate produces immune response in animals: StudyA COVID-19 vaccine candidate currently undergoing early-stage human trials in China can produce a "robust" immune response against the nove...
- 'How coronavirus enters cells decoded, may help develop new drugs'According to the researchers, including those from Icahn School of Medicine at Mount Sinai in the US, understanding how the novel coronavir...
- Coronavirus a product of natural evolution, not lab made: StudyThe analysis of public genome sequence data from SARS-CoV-2 and related viruses found no evidence that the virus was made in a laboratory o...
Load More
